頁籤選單縮合
題名 | 臺灣生物製藥產業發展策略之研究= |
---|---|
作者 | 劉尚志; 徐慶懿; |
期刊 | 交大管理學報 |
出版日期 | 19951200 |
卷期 | 15:2 1995.12[民84.12] |
頁次 | 頁15-37 |
分類號 | 418.41 |
語文 | chi |
關鍵詞 | 生物技術; 製藥; 研發; 臺灣; Biotechnology; Pharmaceutics; R&D; Taiwan; |
中文摘要 | 生物技術產業是二十一世紀最具發展潛力之科技產業,本研究分別從生物技術及製藥產業環境分析著手,經由專家訪談,探討我國生物製藥產業之發展條件與市場發展機會,並發掘出我國生物製藥產業競爭優勢及提出概念性之發展策略。1.產業經營環境分析:國内藥廠由於廠家多、營業額小且研發意願低落,多針對專利過期之原料藥進行開發和各種劑型製劑之仿製,由於產品同質性高,造成殺價競爭,使得經營愈趨困難。2.產業競爭優勢分析:我國生物製藥產業的強處為政府策略性的支持、上游基礎研究趨於世界水準、國内資本充裕及人力資源充沛、廠商擁有良好製造能力;弱處為新藥研發相關基礎設施不完備、生技產業資訊體系不健全,廠商方面則面臨國際化程度低、產品線稀少、製造成本上揚、行銷規劃能力弱及無品牌知名度等問題;環境機會為我國正值實施全民健保及進入高齡化社會,且地理位置靠近大陸及東南亞等有利因素;環境威脅則為國内、外競爭愈趨劇烈、新產品不斷產生。應運用生物技術進行新藥探索、發展生物藥品及藥品製程改良,以減低藥品研發與生產成本。3.策略分析:我國製藥工業未來發展方向可朝向傳統工業昇級(原料藥產業、製劑改良)及高科技生物製藥(生技藥品之研發)產業同時發展。國内中小型藥廠應加速產業轉型,從事生產原料藥及發展新劑型、推展專業自動化生產及接受國外藥廠委託之代工;同時國内上、中游及體質佳的藥廠可共同進行生技藥品的研發與生產,針對世界性醫藥及本土特有疾病的研發成果完成商品化生產,培養國際競爭力。 |
英文摘要 | The Bio-Pharmaceutical products have earned global attention due to the enormous market demand in the near future and next century. However, the Bio-Pharmaceutical industry requires high quality of manufacturing capability, appropriate industrial infrastructures, significant financial support, accessible market channels, and available human capitals. The study examines the industrial environment and status of Taiwan's pharmaceutical industry, which leads to the analysis of prospective market opportunity and industrial R&Ds for Taiwanese firms. The competitive advantage of Taiwanese Bio-Pharmaceutical industry and strategic views on its development are also presented in this study. Biotechnology serves as one of the vehicles for new drug development in an effective manner. Bio-Pharmaceutical drugs is also the mainstream of future drugs, it enhances the pharmaceutical industry by refining manufacturing process and producing new drugs. The study concludes that to upgrade present pharmaceutical industry as well as to collaborate R&Ds for Bio-Pharmaceuticals should be conducted simultaneously. It is recommended that effective use of research funds, enhancement of professional trainings, establishment of industrial infrastructure and construction of information system by governments, R&D investments of the firms, as well as the establishment of international professional prestige, will be the sustaining competitive strategy for Bio-Pharmaceutical industry. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。